Interested in learning about how to navigate resources for student biotech startups?
Looking to work on a startup but don’t yet have an idea you’re passionate about?
Want to hear and potentially join some of this year’s exciting early stage biotech teams out of Harvard and MIT?
Ideation is an annual event during which the Harvard and MIT communities come together to discuss commercializing science and the plethora of funding and development groups dedicated to biotech. Open to anyone in and beyond Boston, attendees will hear from an experienced executive and educator in biotechnology, 2 successful and established student-based teams out of Harvard and MIT, and a series of 3-minute pitchesfrom selected newly formed teams looking to recruit members and share their vision.
Immediately following the event content, at 7:30pm, there will be a networking session with food provided during which students can learn about biotech startup resources from representatives of our partnering organizations, meet pitching teams, and discuss potential future involvement or collaboration.
Ideation 2018 Partners:
Martin Trust Center, the Harvard iLab, the Engine by MIT, MIT $100K, Harvard Undergraduate Biotechnology Association, Sloan Healthcare Group, and HBS Healthcare Group.
Ideation 2018 Speakers:
Dr. Vicki Sato has served as the VP of Research at Biogen and the President of Vertex Pharmaceuticals. Bridging academia and industry, Dr. Sato was also a Professor of Management Practice at HBS with a focus on biotechnology and a Professor of Molecular and Cellular Biology at Harvard. She is Chairman and Co-Founder of Vir Biotechnology, and serves as a current member of the Board of Directors at Bristol Myers Squibb Company, PerkinElmer Corporation, Borg Warner Corporation, Syros Pharmaceuticals, and Denali.
Confer Health aims to provide clinical-grade testing at home with a new diagnostic platform inspired by work at Harvard Medical School. The company’s co-founder and CEO, Dr. Mounir Koussa, will discuss how he built his team and secured early funding. Now venture-backed, the company received early support from the MIT deltaV program at the Martin Trust Center.
Disease Diagnostic Group is focused on screening, tracking, and diagnosing highly infectious tropical diseases. We will hear from the DDG team and its co-founder and CEO Dr. John Lewandowski, an MIT PhD in mechanical engineering. DDG was the 2014 winner of the MIT $100K Launch competition, a USC Marshall Innovation winner, a MassChallenge diamond winner, as well as a MedTech Innovator Semi-finalist.
If you have questions about Ideation, email us at firstname.lastname@example.org.
Send this to a friend